Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 4Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Ulcer 1Stomach Neoplasms 1Peptic Ulcer Hemorrhage 1Lymphoma, B-Cell, Marginal Zone 1Breast Neoplasms 1

Interventions

Oxaliplatin 14sintilimab 10S 1 (combination) 9Drug Therapy 7Capecitabine 5tislelizumab 4Surgical Procedures, Operative 4Paclitaxel 4HMPL-013 4apatinib 3Tegafur 3Immune Checkpoint Inhibitors 3Cisplatin 3Bevacizumab 3surufatinib 2potassium oxonate 2lenvatinib 2irinotecan sucrosofate 2gimeracil 2Observation 2Injections 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorouracil 2Exercise 2Endoscopic Mucosal Resection 2Doxorubicin 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zolbetuximab 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Stomach Neoplasms × Esomeprazole × Clear all
NCT07312370 2026-03-23

Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing

LanZhou University

Phase 4 Not yet recruiting
120 enrolled
Gastrointestinal

Peptic Ulcer Hemorrhage, Stomach Neoplasms, Stomach Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡